IRL790

· Integrative Research Laboratories AB

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IRL790, covering 2018-05-21 to 2020-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Tolerability of IRL790 in Parkinson's Disease Dyskinesia [Phase 2]